Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study

Cited by (579)

Items 501–579 of 579

1. Outcome of Gynecologic Cancer Patients With The Covid-19 Infection : A Systematic Review And Meta Analysis
   I Gde Sastra Winata, Januar Simatupang, Arie Adrianus Polim, Yakob Togar, Advenny Elisabeth Tondang · 2022 · Research Square
2. Monoclonal anti-CD20 antibodies in lymphomas therapy during the COVID-19 pandemic: pro and contra
   K. A. Sychevskaya, С К Кравченко · 2022 · Oncohematology
3. Determinants of clinical course and mortality in COVID-19 patients with hematological disorders: real life data from a single center
   Burak Devecı, Levent Döşemeci, Ayşe ASLAN, Gökhan ASAL, Bilge ÜSTÜN, Meltem YILDIRMER AKAR, Tayfur Toptaş, Mine Yavuz Taşlıpınar, Rabin Saba · 2022 · The European Research Journal
4. UKCCMP-Projekt: COVID-19-Mortalitätsrisiko bei Tumorpatienten
   2020 · TumorDiagnostik & Therapie
5. Mortalidade por Covid-19 em pacientes com câncer de pulmão: uma revisão de literatura
   Nágila Silva Alves, Jaciara Pereira de Moura, Maria Samara da Silva, Layanne Ramalho Jacob, Robson de Araújo Silva, Ana Paula De Carvalho Souza, Thaina Safira Souza da Costa, Fabiane Corrêa do Nascimento, Sirlene Aparecida de Oliveira, Juliana de Souza Henrique et al. · 2021 · Editora Pasteur eBooks
6. COVID-19 outcomes by cancer status, type, treatment, and vaccination
   Maxwell Salvatore, Miriam M. Hu, Lauren J. Beesley, Alison M. Mondul, Celeste Leigh Pearce, Christopher Ryan Friese, Lars G. Fritsche, Bhramar Mukherjee · 2022 · medRxiv
7. The outcome of gynecologic cancer patients with Covid-19 infection: A systematic review and meta-analysis
   I Gde Sastra Winata, Januar Simatupang, Arie Adrianus Polim, Yakob Togar, Advenny Elisabeth Tondang · 2022 · F1000Research
8. PARIS score for evaluation of probability of SARS-CoV-2 infection in cancer patients
   Candice Gueuning, Lieveke Ameye, Angela Loizidou, Bogdan Dragoş Grigoriu, Anne‐Pascale Meert · 2022 · Supportive Care in Cancer
9. In silico analysis of the Key Receptors of SARS-CoV-2: ACE2 and TMPRSS2 in Head and Neck Cancer
   Vignesh Mariappan, Aashika Raagavi JeanPierre, Agieshkumar Balakrishna Pillai · 2022 · Research Square
10. Correlation of the TCR Diversity Indexes in the Peripheral Blood with Disease Susceptibility and Deterioration in COVID-19 Patients
    Yue Zhuo, Jiyuan Zhang, Zhen Zhang, Lifeng Zhang, Xin Yang, Jin‐Wen Song, Xuan Zhao, Jianmin Huang, Xing Fan, Ping Shuai et al. · 2022 · SSRN Electronic Journal
11. Continuation of Temozolomide Chemotherapy in a Glioblastoma Patient Post Resolution of COVID-19 Pneumonia
    2022 · Cancer Studies and Therapeutics
12. The Impact of Covid on The Survival Rate of Cancer Patients. Single Center Study At Moewardi Hospital Indonesia
    Widyanti Soewoto, Ida Bagus Budhi Surya Adnyana, Muhammad Fahmi Salafuddin, Muhammad David Perdana Putra, Galih Santoso Putra, Rizka Vinkan Septiani, Muhamad Muamar, Ikhdin Radiamin Saadhi, Meirisa Ardianti, Dea Alberta Setiawati et al. · 2022 · International Academic Research Journal of Surgery
13. Malignant mesothelioma diagnosis and survival in the time of COVID-19 in Northeastern Italy
    2022 · Medical & Clinical Research
14. COVID-19 Outcomes in Stage IV Cancer Patients Receiving Immune Checkpoint Inhibitors
    Mengni Guo, Jieying Liu, Shuntai Zhou, James B. Yu, Zohaib Ahmed, Sarfraz Ahmad, Manoucher Manoucheri, Mark A. Socinski, Tarek M. Mekhail, Vincent P. Hsu · 2022 · SN Comprehensive Clinical Medicine
15. Meta-analysis of Lung Cancer Patients in COVID-19
    Ramendra Pati Pandey, Gajala Deethamvali Ghouse Peer · 2022 · Current Respiratory Medicine Reviews
16. Comparative analysis of humoral responses to BNT162b2 vaccine among patients with hematologic disorders and organ transplant recipients.
    Hideyuki Nakazawa, Kaoko Sakai, Yuriko Sudo, Ryohei Iwabuchi, Hitoshi Sakai, Sayaka Nishina, Toru Kawakami, Fumihiro Kawakami, Shuji Matsuzawa, Toshiro Ito et al. · 2022 · Transplant Immunology
17. Cancer and COVID-19 in Gaza strip-Palestine: What do we know?
    Amal F Jamee, Wallaa I Alnahhal, Norhan A Abughali, Mohammed K Abed, Sabrin M Zourob, Heba S redwan, Shuruk A Ghunaim · 2022 · World Journal of Advanced Research and Reviews
18. Why is the mortality rate high in RT-PCR negative COVID-19 patients with comorbid diseases?
    Mümtaz Taner Torun, Dilber Durmaz · 2022 · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
19. Cellular Landscaping of COVID-19 and Gynaecological Cancers: An Infrequent Correlation
    Rahul Bhattacharjee, Debanjan Das, Radheka Bhadhuri, Srija Chakraborty, Tanima Dey, Rupam Buragohain, Asim Nath, Kartik Muduli, Pranjan Barman, Rohit Gundamaraju · 2022 · Journal of Oncology
20. Real-world data no the incidence of coronavirus disease (COVID-19) in patients with advanced thoracic cancer during the early phase of the pandemic in Japan
    Akito Fukuda, Tatsuya Yoshida, Shigehiro Yagishita, Mika Shiotsuka, Osamu Kobayashi, Satoshi Iwata, Hitomi Umeguchi, Maatoshi Yanagida, Yasuhiro Irino, Ken Masuda et al. · 2022 · Research Square
21. Cancer Patients’ Health Related Quality of Life (HRQoL) and Its Predictor Factors during the COVID-19 Pandemic: A Cross-sectional Survey Study in China
    Lingyun Sun, Rongyan Peng, Jiaxi Liu, Yunzi Yan, Haibo Zhang, Yufei Yang · 2022 · Research Square
22. HEMATOLOGICAL DISEASES AND COVID-19
    Aline Campos dos Santos Silva, Lucas do Nascimento Freire, Caroline Azevedo Brim, Camilla Vasconcellos Ferreira, Pedro Henrique Gonçalves Neves, Milena Dias Cabral, Karine Vieira da Rocha, Patrick de Abreu Cunha Lopes, Fernanda da Costa Barros Teixeira Carvalhedo · 2022 · International Journal of Health Science
23. Clinical characteristics and risk factors for mortality of hospitalized cancer patients with COVID-2019 in Mecca, Saudi Arabia
    Nabil Ghaleb, Adeeb A. Bulkhi, Eid Humaid Alqurashi, Abdelfattah Touman, Ahmad Aldobyany, Rajaa Alsaggaf, Hanan Mabar, Noureen Murtaza, Ammar Rajab · 2022 · Annals of Thoracic Medicine
24. Impact of the Covid-19 Pandemic on the Lung Cancer Management Process at the Mohamed VI Center for the Treatment of Cancer in Morocco
    Souleymane Panandtigri, Nadia Benchakroun, El Karim SYLLA Abdou, Tarik Chekrine, Mouna Bourhafour, Zineb Bouchbika, H. Jouhadi, Nezha Tawfiq, Samira Nani, S. Sahraoui · 2022 · International Journal of Oncology Research
25. HUBUNGAN PEMBERIAN KEMOTERAPI PADA PASIEN KANKER DENGAN KEJADIAN INFEKSI COVID-19
    Octaviana Maria Simbolon, Habel Roy Sulo · 2022 · MEDFARM Jurnal Farmasi dan Kesehatan
26. COVID-19 INFECTION IN PATIENTS WITH MULTIPLE MYELOMA (REVIEW ARTICLE)
    Галанин Владислав Васильевич, Ирина Владимировна Демко, Бахтина Варвара Ивановна, A.A. Gordo, Д. В. Белоногов, E.S. Kochergina · 2022 · Bulletin of Medical Science
27. The Importance of Recency of Cancer Diagnosis in Patients Hospitalized with COVID-19—Glimpses from an EHR-based Study
    Pamela Egan, Chinmay Jani, Harpreet Singh, Sanjay Mishra, Jeremy Lyle Warner · 2023 · Cancer Epidemiology Biomarkers & Prevention
28. Recommendations for prevention of SARS-CoV-2 infection in immunocompromised patients
    Krzysztof Tomasiewicz, Alicja Maria Dębska-Ślizień, Magdalena Durlik, Krzysztof Giannopoulos, Iwona Hus, Piotr Lukasz Rutkowski · 2023 · Hematologia
29. Covid-19 and cancer: impact on diagnosis, care and therapy
    Said Abdallah Nabil, Berjas Abumsimir, Abdelilah Laraqui, Moulay Mustapha Ennaji · 2023 · Elsevier eBooks
30. Factors affecting COVID-19 disease severity in breast cancer patients: Single-Center experience
    Semra Özkan, Zehra Kocaman, Ali̇ İnal · 2023 · Medical Science and Discovery
31. Abstract P4-07-39: NEOADYUVANT TREATMENT IN THE COVID ERA
    Beatriz Alonso de Castro, Igor Gómez‐Randulfe, Sofía Silva Díaz, Cristina Reboredo, Silvia Antolín, Eva Pérez López, Patricia Cordeiro, Rocío Lesta, Iria Parajó Vázquez, Lourdes Calvo · 2023 · Cancer Research
32. Uncovering biomarkers for potential therapeutic targeting for COVID-19-related acute kidney injury: A bioinformatic approach
    Rui Gong, Gangyu Long, Qian Wang, Qiongya Wang, Chaolin Huang, Dingyu Zhang · 2023 · Journal of Translational Critical Care Medicine
33. Data from Preexisting and Post–COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer
    Tatjana Bilich, Malte Roerden, Yacine Maringer, Annika Nelde, Jonas S. Heitmann, Marissa Lisa Dubbelaar, Andreas Peter, Sebastian Hörber, Jens Bauer, Jonas Rieth et al. · 2023
34. Construção e validação de uma tecnologia educativa com base na percepção de pacientes e profissionais de saúde da oncologia sobre a pandemia da COVID-19: um instrumento de prevenção de agravos e promoção da saúde
    Isabella Portugal · 2023
35. The Effects of Nasocomial SARS-CoV-2 Infection after Elective Gastrointestinal Oncologic Procedures: Single Center 30-day Follow-up Results
    Serdar Şenol, Mustafa Kuşak · 2023 · Prague Medical Report
36. Impact of admission viral load on respiratory outcomes in hospitalized SARS-CoV-2 infected patients with cancer and without cancer: A 2-, 4- and 6-months follow-up prospective study
    Maha Al-Mozaini, ATM Rezaul Karim, Syed Shahidul Islam · 2023 · Journal of Infection and Public Health
37. Seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in patients with cancer and the impact of anti-tumor treatment on antibodies*
    Bili Wu, Bo Liu, Xueyan Jiang, Ye Yuan, Wan Qin, Kai Qin, Qi Mei, Li Zhang, Huilan Zhang, Guangyuan Hu et al. · 2021 · Oncology and Translational Medicine
38. Characteristics and Outcomes of COVID-19 Cancer Patients Admitted to a Portuguese Intensive Care Unit: A Case-Control Study
    Ridhi Ranchor, Nuno Pereira, Ana R. Medeiros, Manuel Magalhães, A. Marinho, António Araújo · 2023 · Cancers
39. COVID-19 mortality and risk factors in patients with cancer in Ecuador: A retrospective, non-randomized, controlled study
    Evelyn Valencia-Espinoza, M. Cabezas, Andrea Plaza Rodríguez, Katherine García, Carlos Calle Caamaño, Marco Fornasini, J. Luna, Camila Miño · 2023 · Medicine
40. Retrospective analysis of COVID-19 among 391 hospitalized patients in the Henan province of China
    Yang Dong, Suyan Luo, Yali Wang, Yujie Shi · 2023 · Medicine
41. An Observational Study of Risk Factors for SARS-CoV 2 Infection in Patients with Cancer
    Sonam Singla, Teena Wadhwa, Charu Yadav, Manish Kumar Singh, Smita Sarma, Nitin Sood, Ashok Kumar Vaid · 2023 · European Journal of Clinical Medicine
42. COVID-19 Infection After Different Combinations of Vaccines in Patients with Solid Tumors
    Oktay Ünsal · 2023 · Eurasian Journal of Medical Investigation
43. An Assessment of COVID-19 Infectivity and Fatality: Meta-analysis Study
    Evin Kırmızıtoprak, Tülay Ortabağ · 2023 · Namık Kemal Tıp Dergisi
44. The Impact COVID-19 Infection on Cancer Patients: A Tertiary Cancer Center Experience in Jordan
    Kamal Hosni Al-Rabi, Fadwa Alqadi, Akram Al‐Ibraheem, Khalid Halahleh, Samer H. Salah, Hazim Ababneh, Mohammad Akkawi, Maher A. Sughayer, Lana Tafesh, Layan abo Abed et al. · 2023 · Cureus
45. Clinical Characteristics and Outcomes in Hospitalized Patients with COVID-19 and Cancer History: A Multicenter Cross-Sectional Study in Southwestern Iran
    Javad Zarei, Abbas Sheikhtaheri, Mehrnaz Ahmadi, Maria Cheraghi, Abdolhassan Talaiezadeh, Adeleh Khazami · 2024 · International Journal of Hematology-Oncology and Stem Cell Research
46. Impact of Corticosteroid Therapy on ICU Patient Outcomes in Severe COVID-19 Cases: A Retrospective Cohort Study in Saudi Arabia
    Lama Tariq Alkhunaizi, Jawza Ali Almutairi, Sarah Hamad Almanea, Shuruq Mohammed H. Alzahuf, Mohammed Fehaid, Abdulaziz Khalaf Zayed Alharthi, Tameem Mohammad Alhebs, Sarah Mousa Alshuqayfi, Rana S Alotaibi, Meshari Alharbi et al. · 2024 · Cureus
47. WITHDRAWN: A Survey on the Attitude and Willingness of Chinese Cancer Patients toward a COVID-19 Booster Vaccine
    Man Yao, Peng Wang, Meng Wang, Sheng-qi Zheng, Xiaowan Xu, Qingmei Zhang, Qin Yu, Hao-ran Qin, Yong-bin Meng, Jing Hong · 2024 · Heliyon · Retracted
48. AVANÇOS NO ENTENDIMENTO DA PATOGENIA DA COVID-19: UMA REVISÃO
    Gilcele de Campos Martin Berber, Renata Dezengrini Slhessarenko · 2024 · Arquivos de Ciências da Saúde da UNIPAR
49. COVID-19: RISK, CLINICAL OUTCOMES AND MECHANISM AMONG PATIENTS WITH CANCER
    Asmida Isa, Hanis Nabilah Mohd Nazman · 2023 · Journal of Health and Translational Medicine
50. The clinical presentation and outcomes of COVID-19 in immunocompromised hosts in comparison to comorbid and immunocompetent patients: retrospective study of 384 cases
    Ziya Karimov, Gunay Huseynova, Hakan Kiriş, Cansu Tongel, Aynur Aliyeva, Nur Soyer, Nigar Abdullayeva, Ömer Selim Unat, Özen K. Başoğlu, Abdullah Sayıner et al. · 2024 · Ege Tıp Dergisi
51. Factor Associated with Mortality of Hospitalized Cancer Patients with COVID-19 Infection in Indonesia National Cancer Center
    Sri Agustini Kurniawati, Noorwati Sutandyo, Hilman Tadjoedin, Jaka Pradipta, Ratu Ralna Ismuha, Citra Dovina Khaira Ummah, Kresna Dharma Suryana, Erwin Budi · 2024 · Indonesian Journal of Cancer
52. Palliative Care Utilization Among Hospitalized Patients With Hepatocellular Cancer: A Nationwide Study in the Pandemic Era (2019-2021)
    Kim Abbegail Tan Aldecoa, Chef Stan L. Macaraeg, Marwan S. Abougergi, Geetha Krishnamoorthy, Camelia Arsene · 2024 · American Journal of Hospice and Palliative Medicine®
53. Impact of COVID-19 infection on genitourinary cancer management. SOGUG-COVID-19: A spanish, multicenter, observational study
    Natalia Vidal, Miguel Ángel Climent, Sara Pérez, María José Méndez-Vidal, Geòrgia Anguera, Imanol Martínez Salas, Enrique Gallardo, M. Andres Cuellar, Javier Molina‐Cerrillo, Almudena Martín et al. · 2024 · Clinical & Translational Oncology
54. Neutralizing antibodies and safety of a COVID-19 vaccine against SARS-CoV-2 wild-type and Omicron variants in solid cancer patients
    Busayamas Chewaskulyong, Pattarapong Satjaritanun, Thanika Ketpueak, Thatthan Suksombooncharoen, Chaiyut Charoentum, Nuttaphoom Nuchpong, Apichat Tantraworasin · 2024 · PLoS ONE
55. Identification of potent TMPRSS4 inhibitors through structural modeling and molecular dynamics simulations
    Ismail Hdoufane, Mehdi Oubahmane, Youssef Habibi, Christelle Delaite, Mohammed Mater Alanazi, Driss Cherqaoui · 2025 · Scientific Reports
56. Shorter Time to Biopsy of Patients with Head and Neck Squamous Cell Carcinoma During the COVID-19 Pandemic in Hungary
    Éva Szabó, Eszter Kopjár, László Rumi, Szabolcs Bellyei, Antal Tamás Zemplenyi, Emese Mátyus, Eszter Édes, János Girán, István Kiss, István Szanyi et al. · 2025 · Cancers
57. ELECTIVE GYNECOLOGICAL SURGERY DURING COVID-19 PANDEMIC: A SINGLE CENTER EXPERIENCE
    Rıza Dur, Fatih Çelik, Betül Ahat, Mariam Chkhikvadze, Ayşe Yalçınkaya Yılmaz, Mine Kanat Pektas · 2025 · Kocatepe tıp dergisi.
58. Differences in COVID-19-Related Hospitalization, Treatment, Complications, and Death by Race and Ethnicity and Area-Level Measures Among Individuals with Cancer in the ASCO Registry
    Adiba Ashrafi, Yong Lin, Angela J. Fong, Jessica Y. Islam, Tiffany C. Turner Anderson, Shridar Ganesan, Carolyn J. Heckman, Adana A. M. Llanos · 2025 · Cancers
59. Wearing a surgical mask during chemotherapy session is safe
    Ali Alkan, Mert Şahin, Ece Dilan Bozkurt, Aslı Alkan, Özgür Tanrıverdi · 2025 · Scientific Reports
60. Sociodemographic, medical, health behavior, and psychosocial factors associated with COVID-19 diagnoses in the New Jersey cancer survivor cohort
    Sharon L. Manne, Adana A. M. Llanos, Hari Subramaniam Iyer, Lisa E. Paddock, Katie A. Devine, Shawna V. Hudson, Denalee M. O’Malley, Elisa Victoria Bandera, Sara Frederick, Jacintha Peram et al. · 2025 · Cancer Causes & Control
61. The interaction between cancer and COVID-19: Risk factors and targeted interventions
    L. da Silva Viana, Alython Araujo Chung, G. T. Monteiro, Andréa Sobral · 2025 · PLoS ONE
62. SARS-CoV-2 infection and its effects on toxicity and survival in non-metastatic nasopharyngeal carcinoma: a matched cohort study
    Xiaoping Lin, Fei Mo, Bin Zhang, Yufei Pan, Jinxuan Dai, Shu-Fang Liao, Yunyan Mo, Xiangyun Kong, Wei Jiang · 2026 · BMC Cancer
63. Epidemiologic and Clinical Characteristics of Cancer Patients Presented to the Emergency Service with COVID-19 Symptoms
    Arzu Babacan · 2025 · International Journal of General Medicine
64. Prediction of mortality in cancer patients with COVID-19 using machine learning methods
    Arzu Babacan · 2025 · Medicine
65. A survey on the attitude and willingness of Chinese cancer patients toward a COVID-19 booster vaccine
    Man Yao, Peng Wang, Meng Wang, Sheng-qi Zheng, Xiao-wan Xu, Qing-mei Zhang, Qin Yu, Hao-ran Qin, Yong-bin Meng, Jing Hong · 2024 · Research Square
66. Additional file 1 of Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis
    Kochawan Boonyawat, Pichika Chantrathammachart, Pawin Numthavaj, Nithita Nanthatanti, Sithakom Phusanti, Angsana Phuphuakrat, Pimjai Niparuck, Pantep Angchaisuksiri · 2020 · Figshare
67. Assessing COVID-19 Infection and Severe Disease Risk in Cancer Patients and Survivors: The Role of Vaccination Status, Circulating Variants, and Comorbidities—A Population-Based Study in Northern Italy
    Massimo Vicentini, Pamela Mancuso, Francesco Venturelli, Sergio Mezzadri, Eufemia Bisaccia, Alessandro Zerbini, Lucìa Mangone, Paolo Giorgi Rossi, on behalf of the Reggio Emilia COVID-19 Working Group · 2025 · Vaccines
68. Predicting Adverse Outcomes via Simple Assessment Tools Among Older Inpatients With Nonsevere COVID‐19: The SARC‐F Score, FRAIL Scale, and G8 Questionnaire
    Betul Cigdem Yortanli, Muhammet Cemal Kızılarslanoğlu, Betul Kozanhan, İbrahim Solak, Fatma Kaçar, Dilek Ateş, Mehmet Mermer, Korhan Kollu · 2026 · International Journal of Clinical Practice
69. Influence of COVID-19 pandemic on colon cancer presentations
    Arina Cipriana Pietreanu, Antonia Ioana Vasile, Cornel Dragoș Cheregi, Simona Trifu, Bogdan Mihai Cristea, Bogdan Socea · 2026 · Frontiers in Oncology
70. DT-13 ameliorates LPS-induced acute lung injury via targeting NMMHC IIA to modulate the FOXO1/KLF2/SPHK1 pathway
    Jiazhi Zhang, Jiahui Tang, Huifen Ma, Ziqian Pan, Mengxue Xiao, Jianhao Zhou, Ling Zhang, Shuaishuai Gong, Fang Li, Boyang Yu et al. · 2026 · Acta Materia Medica
71. Spatiotemporal distribution of people hospitalized with cancer and COVID-19 in Rio de Janeiro, Brazil: two years of pandemic
    Lucian da Silva Viana, Gustavo Menezes Silva Damasceno, Gina Torres Rego Monteiro, Andrea Sobral · 2026 · Ciência & Saúde Coletiva
72. Distribuição espaço-temporal de pessoas hospitalizadas com câncer e COVID-19 no Rio de Janeiro, Brasil: dois anos de pandemia
    Lucian da Silva Viana, Gustavo Menezes Silva Damasceno, Gina Torres Rego Monteiro, Andrea Sobral · 2026 · Ciência & Saúde Coletiva
73. Immune assessment of COVID-19 acute disease: associations with disease severity and implications for post-acute outcomes
    Shelby Devin, Kyce Darouiche, Silvana Valdebenito, Maximiliano Rovegno, Eliseo A. Eugenín · 2026 · NeuroImmune Pharmacology and Therapeutics
74. COVID-19 mortality risk among women with ovarian cancer: a matched case-control study
    Karoline PI Peruchi, Víctor Alexandre Félix Bastos, Lorena Alves Teixeira, Franklin Fernandes Pimentel, Francisco José Cândido dos Reis · 2026 · Brazilian Journal of Medical and Biological Research
75. Mortality Rate and Effects of COVID-19 in Cancer Patients versus Non-cancer Patients: A Propensity Score Matching Study
    Fatemeh Ghadamgahi, Malihe Safari, Javad Faradmal, Saeid Bashirian, Ali Reza Soltanian, Salman Khazaei, Ghodratollah Roshanaei · 2023 · The Open Public Health Journal
76. A review on in-silico analysis of immune cell trafficking and interactions with the tumour microenvironment
    Kharan P., Amy S. Mathew, Payel Ghosh, Syama H.P. · 2026 · Frontiers in Oncology
77. Comparative Analysis of Survival Outcomes in Ovarian Cancer Patients: Pre-COVID vs. COVID Era
    Luxitaa Goenka, Veena Pampapati, Latha Chaturvedula, Jayalakshmi Durairaj, Prasanth Ganesan · 2026 · Indian Journal of Medical and Paediatric Oncology
78. Extensively drug-resistant ESBL-producing enterobacterales and coexisting antimicrobial resistance genes are associated with mortality in critically ill patients with cancer
    Samah Mohammed Refay, Noha Gaber Sayed, Waleed M. El-Kazzaz · 2026 · Scientific Reports
79. Impact of COVID-19 on TB and HIV/AIDS severity in low- and middle-income countries: a systematic review
    Endawoke Amsalu, Melese Yeshambaw, Dagim Jirata · 2026 · Dialogues in Health